XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.2

STOCKHOLDERS’ EQUITY (DEFICIT) & STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Sep. 30, 2021

Equity [Abstract]

Schedule of Fair Value Assumptions

The following assumptions were used in the fair value method calculations:

Schedule of Fair Value Assumptions

STOCKHOLDERS' EQUITY (DEFICIT) & STOCK-BASED COMPENSATION

		Three Months Ended September 30,								Six Months Ended September 30,
		2021				2020				2021				2020
Risk-free interest rates			0.8% - 0.98%				0.28% - 0.37%				0.8% - 0.98%				0.28% - 0.37%
Volatility			367% - 370%				88% - 127%				89% - 370%				88% - 128%
Expected life (years)			5.0 - 6.2				5.0 - 6.0				5.0 - 6.2				5.0 - 6.0
Dividend yield			—				—				—				—

Schedule of Stock Option activity

A summary of stock option activity under the Plan is presented below:

Schedule of Stock Option activity

STOCKHOLDERS' EQUITY (DEFICIT) & STOCK-BASED COMPENSATION (Details 2)

						Options Outstanding
										Weighted
		Shares								Average
		Available				Number of				Exercise
		for Grant				Shares				Prices
Balance at March 31, 2021			408,245				3,591,755			$	1.75
Options granted			(182,321	)			182,321				4.23
Share awards			(5,508	)			—				—
Options cancelled and returned to the Plan			22,639				(22,639	)			2.87
Balance at June 30, 2021			243,055				3,751,437				1.86
Additional shares authorized under the Plan			4,000,000				—				—
Options granted			(1,189,150	)			1,189,150				4.05
Share awards			(10,906	)			—				—
Options cancelled and returned to the Plan			147,639				(147,639	)			2.34
Balance at September 30, 2021			3,190,638				4,792,948				2.39

Schedule of Outstanding and Exercisable Option, Range

The following table summarizes the range of outstanding and exercisable options as of September 30, 2021:  

Schedule of Outstanding and Exercisable Option, Range

STOCKHOLDERS' EQUITY (DEFICIT) & STOCK-BASED COMPENSATION (Details 3)

		Options Outstanding												Options Exercisable
Range of Exercise Price		Number Outstanding				Weighted Average Remaining Contractual Life (in Years)				Weighted Average Exercise Price				Number Exercisable				Weighted Average Exercise Price				Aggregate Intrinsic value
$0.66 - $5.90			4,792,948				8.09			$	2.39				2,609,002			$	1.54			$	4,022,239

X

- References

No definition available.

+ Details

Name:	modd_DisclosureStockBasedCompensationDetails2Abstract
Namespace Prefix:	modd_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	modd_DisclosureStockBasedCompensationDetails3Abstract
Namespace Prefix:	modd_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	modd_DisclosureStockBasedCompensationDetailsAbstract
Namespace Prefix:	modd_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (k)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

+ Details

Name:	us-gaap_ScheduleOfAssumptionsUsedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration